NCR3 and cancer: To understand this selective activation, we analyzed activating and inhibitory ligand expression in target cells B7-H6, the primary ligand for NKp30, was significantly upregulated in cancer cells but nearly absent in normal cells (Figure 5C; Supplementary Figure 5A).